[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

HealthTree Cure Tour Workshop: Salt Lake City (In-Person) with Dr. Douglas Sborov

HealthTree Cure Tour Workshop: Salt Lake City (In-Person) with Dr. Douglas Sborov image

HealthTree Cure Tour Workshop: Salt Lake City (In-Person) with Dr. Douglas Sborov

HealthTree Foundation for Multiple Myeloma
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Join us for our in-person workshop on July 2nd at 5:30 PM MT. This will be an interactive session where you’ll discover how HealthTree is leveraging innovation to drive lifesaving research through HealthTree Cure Hub®. Dr. Douglas Sborov from Huntsman Cancer Institute will be on hand to talk about potential causes of blood clot and how to prevent them and CAR-T use in older patients.

Bring your questions and a laptop! There will be a Q&A session with Dr. Sborov, and HealthTree's team will help you connect to HealthTree Cure Hub, our free tool that helps you understand your health, manage your care, and seamlessly contribute to research. As a Cure Contributor, you join a community of empowered patients using technology to live longer and better with myeloma.

There is no cost to attend. Registration, parking, and a light dinner are free. This meeting is open to patients with multiple myeloma, lymphoma, leukemia and MPNs.

Why Attend?

Learn all the ways HealthTree Cure Hub technology works for you:

 

Meeting Details

  • Meeting date: Tuesday, July 2nd, 2024 at 5:30 PM 
  • Location: RS Auditorium at Huntsman Cancer Institute
  • Registration, parking, and a light dinner are free
  • Please bring your laptop and any necessary passwords to open or use your computer

Questions?

For questions about registration, contact us at +1-800-709-1113 or support@healthtree.org.

For all other questions, contact curetour@healthtree.org.

 

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio
The panelist Douglas Sborov, MD
Douglas Sborov, MD

Dr. Douglas Sborov is an Assistant Professor in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah School of Medicine. He was born and raised in Minnesota, completed his undergraduate education with a Bachelor of Science at the University of Wisconsin-Madison, later completed medical school through the American University of the Caribbean, and spent 3 years in Salt Lake City for his internal medicine residency. After almost 5 years in Columbus, OH, completing hematology, oncology, and bone marrow transplantation fellowships and joining the Division of Hematology as a Clinical Instructor, he and his family were drawn back to the beauty of the Wasatch Front where he joined the Division of Hematology to continue his career as a clinical trialist focused on the treatment of patients with hematologic malignancies. Dr. Sborov is the Director of the Multiple Myeloma Program, an Associate Member of the Huntsman Cancer Institute Experimental Therapeutics Program, Physician Leader of the Multiple Myeloma/Bone Marrow Transplant arm of the HCI Clinical Trials Office (CTO), and an active member of the HCI Protocol Review and Monitoring Committee.

Read Bio

Location

RS Auditorium at Huntsman Cancer Institute

2000 Cir of Hope Dr, Salt Lake City, UT 84112, USA

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

newsletter icon

Get the latest thought leadership on your B-Cell Prolymphocytic Leukemia delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.